Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Primary Biliary Cirrhosis

In brief

The purpose of this study is to determine if the combination of ursodeoxycholic acid (UDCA) and fenofibrate is more effective than UDCA alone in the treatment of primary biliary cirrhosis.

Key facts

Study ID

NCT01141296

Run by

University of Miami

People needed

0

Starts

2011-04-01

Last updated by the study team

2014-04-02

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 21 and ≤ 75 years old
• Established diagnosis of PBC and positive AMA
• Previous treatment with UDCA 13-15 mg/kg/day for at least 1 year
• Incomplete response to UDCA defined as serum ALP ≥ 2 times the upper limit of normal on two separate measurements despite at least 1 year of therapy with UDCA
• Female patients of childbearing age need a negative pregnancy test performed within 7 days of enrollment, and need to be on adequate contraception throughout the study period
• Signed informed consent after careful review of information and study details

You may not qualify if…

• Hypersensitivity to fenofibrate
• Administration of the following drugs at any time during the 3 months prior to screening for the study: methotrexate, colchicines, azathioprine, systemic steroids.
• Prisoners and institutionalized subjects, pregnant or nursing women
• Anticipated need for liver transplantation within one year (estimated 1-year survival <80% as predicted by the Mayo risk score).
• Recipients of liver transplantation
• Recurrent variceal hemorrhage, uncontrolled encephalopathy or refractory ascites
• Co-existing liver diseases such as acute or chronic viral hepatitis, alcoholic liver disease, choledocholithiasis, autoimmune hepatitis, biopsy-proven non-alcoholic fatty liver disease, Wilson's disease and hemochromatosis
• Acute or chronic renal failure, defined as GFR < 60 ml/min
• Known history of cholecystitis with intact gallbladder
• History of, or known high risk for, venous thromboembolism
• Current use of warfarin or statins

Where it is running

• University of Miami — Miami, Florida, United States
• Mayo Clinic Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.